ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,111, issued on July 28, was assigned to Epizyme Inc. (Cambridge, Mass.). "SETD2 inhibitors and related methods and uses, including combinat... Read More
ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,112, issued on July 28, was assigned to Janssen Pharmaceutica NV (Beerse, Belgium). "FGFR tyrosine kinase inhibitors for the treatment of u... Read More
ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,113, issued on July 28, was assigned to AstraZeneca AB (Sodertalje, Sweden). "Therapeutic combinations of acalabrutinib and capivasertib to... Read More
ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,114, issued on July 28, was assigned to The Medical College of Wisconsin Inc. (Milwaukee). "Compositions for inhibition of herpesviruses" w... Read More
ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,115, issued on July 28, was assigned to MARSHALL UNIVERSITY RESEARCH Corp. (Huntington, W.va.). "Methods for treatment of obesity, atherosc... Read More
ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,116, issued on July 28, was assigned to The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. (Bethesda, Md.). "SET... Read More
ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,117, issued on July 28, was assigned to ELI LILLY AND COMPANY (Indianapolis). "KRAS inhibitors" was invented by Sean Aronow (Boulder, Colo.... Read More
ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,118, issued on July 28, was assigned to Saint Joseph's University (Philadelphia). "Allosteric agonists and positive allosteric modulators o... Read More
ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,119, issued on July 28, was assigned to PTC Therapeutics MP Inc. (Warren, N.J.) and Virginia Commonwealth University (Richmond, Va.). "Meth... Read More
ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,120, issued on July 28, was assigned to LIQMEDS WORLDWIDE Ltd. (Weedon, Great Britain). "Liquid oral formulations for PDE V inhibitors" was... Read More